据外媒新闻，美国FDA要求辉瑞和葛兰素史克（GSK）生产的呼吸道合胞病毒（RSV）疫苗须在标签上增加有关罹患吉兰-巴雷综合征（GBS）风险的警告。吉兰-巴雷综合征是一种罕见的神经系统疾病，其病因可能与感染和免疫反应有关，特征性症状为对称性的肢体无力、 ...

As for GBS itself, this neurological ailment can be severe, attacking nerves and warranting hospitalisation for weeks or ...

On Tuesday, January 7, the FDA announced it would now be requiring GSK and Pfizer’s RSV vaccines to hold warnings of a risk ...

智通财经APP获悉，美国食品和药物管理局(FDA)表示，葛兰素史克(GSK.US)和辉瑞(PFE.US)生产的一种常见呼吸道病毒疫苗必须附有警告，说明这些疫苗可能会增加一种罕见的神经系统副作用的风险，这种副作用可能导致瘫痪。该机构在周二发布的一份安全 ...

The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

“我们发现，平均而言，免疫功能低下的老年人在接种疫苗后产生的针对RSV的抗体较少，而在用于验证疫苗的临床试验中，60岁以上的健康人产生了非常强烈的反应。此外，免疫功能低下者的抗体水平变化很大，一些研究参与者因接种疫苗而表现出免疫力的强烈增强，而另一些人则几乎没有反应。” Andrew Karaba博士说。

Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.

Read about vaccine sales, Akums and more in the latest Market Talks covering Health Care.

Investing.com -- 美国食品和药物管理局（FDA）周二指示，由葛兰素史克（GSK）和辉瑞制药公司开发的一种常见呼吸道病毒疫苗必须包含关于罕见神经系统副作用的警告。 PFE 频登热榜，问题在于：真的值吗？

A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s ...

Before the RSV vaccines were approved, the FDA flagged potential GBS risks with the vaccines. After approval, the CDC ...